Turtlemint IPO Allotment Status: Check on Kfin Tech, NSE & BSE

Md Salman Ashrafi Image

Md Salman Ashrafi

Last updated:
3 min read
Turtlemint IPO Allotment Status: KFinTech, BSE, NSE
Table Of Contents
  • Important Dates
  • How to Check Turtlemint IPO Allotment Status
  • Turtlemint IPO Subscription Details
  • Turtlemint IPO GMP Update
  • What’s Next After Allotment?
  • Final Word

Turtlemint IPO allotment is expected to be finalized on June 24, 2026. The IPO received a modest overall subscription of 1.24 times, with qualified institutional buyers (QIBs) showing the strongest interest. Investors can now check their allotment status through Kfin Technologies, NSE, or BSE.

This blog explains how to check allotment status, subscription details, GMP trends, and what investors should expect next.

Important Dates

  • Allotment Date: June 24, 2026
  • Refund Initiation: June 25, 2026
  • Demat Credit: June 25, 2026
  • Listing Date: June 29, 2026

How to Check Turtlemint IPO Allotment Status

Method 1: Check on BSE

  • Visit the BSE IPO allotment page: https://www.bseindia.com/investors/appli_check
  • Select "Equity" under Issue Type.
  • Choose "Turtlemint Fintech Solutions Limited" from the issue list.
  • Enter your Application Number or PAN.
  • Complete the verification and click Search.

Method 2: Check on NSE

Method 3: Check on KFinTech (Registrar)

  • Visit the Kfin Technologies IPO allotment: https://ipostatus.kfintech.com/
  • Select Turtlemint IPO from the dropdown menu.
  • Choose any one option: Application Number, PAN, or DP Client ID.
  • Enter the required details.
  • Click Submit to check your allotment status.

Turtlemint IPO Subscription Details

CategorySubscription
QIB (Qualified Institutional Buyers)1.6x
NII (Non-Institutional Investors)0.53x
RII (Retail Individual Investors)1.11x
Total1.2x

Source: INDmoney

What do these numbers indicate?

  • Demand was largely driven by institutional investors, with the QIB portion subscribed 1.6 times.
  • Retail participation remained healthy at 1.11 times, although demand was not exceptionally strong.
  • The IPO witnessed a significant jump on the final day, with total subscription moving from 0.54 times on Day 2 to 1.2 times at close, reflecting typical last-day participation from institutional investors.

Turtlemint IPO GMP Update

Turtlemint IPO's Grey Market Premium (GMP) has weakened steadily during the subscription period. The GMP stood at ₹3 when the issue opened, but gradually declined to ₹0 by allotment day.

At the latest GMP of ₹0, the estimate suggests neutral market sentiment toward the IPO.

Disclaimer: GMP is unofficial and highly volatile. It should not be considered a reliable indicator of actual listing performance.

Also Read: Turtlemint IPO Review: A Powerful Distribution Network, but Can It Deliver Profits?

What’s Next After Allotment?

If Shares Are Allotted

  • If you receive an allotment, the status will be visible on the KFin Tech, NSE, or BSE website once the allotment is finalized.
  • The shares will be credited to your Demat account on June 25, 2026. Investors who applied for multiple lots may receive partial allotment depending on demand and the allotment process.
  • After shares are credited, the next milestone is listing on the stock exchanges on June 29, 2026.

If Shares Are Not Allotted

  • If you do not receive shares, the blocked amount in your bank account should be released, or the refund process should begin on June 25, 2026.
  • Given that the IPO was oversubscribed, not every applicant could receive shares. Investors who remain interested in the company can also consider buying the stock from the secondary market after listing, subject to their own research and risk appetite.

Final Word

Turtlemint IPO received moderate demand, with institutional investors showing greater confidence than retail and non-institutional investors. The subscription data suggests interest in the business, but not the kind of overwhelming demand often seen in highly sought-after IPOs.

Investors should now focus on allotment status, monitor listing-day developments, and evaluate the company's long-term execution rather than relying solely on GMP or short-term market sentiment.

Share: